The Current Ratio as of December 2025 (TTM) for Hisamitsu Pharmaceutical Co., Inc. (HTSUF) is 4.29

According to Hisamitsu Pharmaceutical Co., Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.29. This represents a change of 9.54% compared to the average of 3.92 of the last 4 quarters.

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) Historical Current Ratio (quarterly & annually)

How has HTSUF Current Ratio performed in the past?

The mean historical Current Ratio of Hisamitsu Pharmaceutical Co., Inc. over the last ten years is 5.24. The current 4.29 Current Ratio has changed 8.09% with respect to the historical average. Over the past ten years (40 quarters), HTSUF's Current Ratio was at its highest in in the May 2021 quarter at 7.41. The Current Ratio was at its lowest in in the May 2024 quarter at 3.50.

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Hisamitsu Pharmaceutical Co., Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) Average Current Ratio

How has HTSUF Current Ratio performed in the past?

The current Current Ratio of Hisamitsu Pharmaceutical Co., Inc. (HTSUF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) Current Ratio vs. Peers

How is HTSUF’s Current Ratio compared to its peers?

Hisamitsu Pharmaceutical Co., Inc.’s Current Ratio is greater than Dermapharm Holding SE (1.84), greater than Tsumura & Co. (4.26), less than China Medical System Holdings Limited (5.78), greater than Sihuan Pharmaceutical Holdings Group Ltd. (1.75), greater than Curaleaf Holdings, Inc. (1.47), greater than Fagron N.V. (1.76), greater than Almirall, S.A. (2.39), greater than CanSino Biologics Inc. (3.62), less than HUTCHMED (China) Limited (4.65), greater than BioArctic AB (publ) (4.18),

Build a custom stock screener for Hisamitsu Pharmaceutical Co., Inc. (HTSUF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hisamitsu Pharmaceutical Co., Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hisamitsu Pharmaceutical Co., Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.